Which has better earnings and valuation, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 17.67 -$416.28M -$3.39 N/A Natera $2.31B 14.58 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media favor GH or NTRA?

In the previous week, Natera had 2 more articles in the media than Guardant Health. MarketBeat recorded 11 mentions for Natera and 9 mentions for Guardant Health. Natera's average media sentiment score of 0.99 beat Guardant Health's score of 0.10 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BTSG or NTRA?

In the previous week, Natera had 8 more articles in the media than BrightSpring Health Services. MarketBeat recorded 11 mentions for Natera and 3 mentions for BrightSpring Health Services. Natera's average media sentiment score of 0.99 beat BrightSpring Health Services' score of 0.88 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor FMS or NTRA?

In the previous week, Natera had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for Natera and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 0.99 beat Fresenius Medical Care AG & Co. KGaA's score of 0.85 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, NTRA or HIMS?

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 14.58 -$208.16M -$1.63 N/A Hims & Hers Health $2.37B 3.22 $128.37M -$0.09 N/A

Is NTRA or HIMS more profitable?

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% Hims & Hers Health -0.56% 6.10% 1.52%

Does the media refer more to NTRA or HIMS?

In the previous week, Hims & Hers Health had 14 more articles in the media than Natera. MarketBeat recorded 25 mentions for Hims & Hers Health and 11 mentions for Natera. Natera's average media sentiment score of 0.99 beat Hims & Hers Health's score of 0.55 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 12 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, NTRA or PACS?

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Natera $2.31B 14.58 -$208.16M -$1.63 N/A PACS Group $5.29B 1.12 $191.54M $1.56 23.90

Is NTRA or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Natera -9.05% -14.74% -10.27% PACS Group 4.49% 26.47% 4.36%

Does the media favor NTRA or PACS?

In the previous week, Natera had 1 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for Natera and 10 mentions for PACS Group. Natera's average media sentiment score of 0.99 beat PACS Group's score of -0.05 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Natera (NTRA) Competitors

$234.76 +5.96 (+2.60%)

Closing price 06/23/2026 04:00 PM Eastern

Extended Trading

$235.62 +0.86 (+0.37%)

As of 05:39 AM Eastern

Compare

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Natera stock or one of its competitors? MarketBeat compares Natera with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Natera include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Natera compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

Guardant Health currently has a consensus target price of $141.95, indicating a potential upside of 8.50%. Natera has a consensus target price of $257.71, indicating a potential upside of 9.77%. Given Natera's higher probable upside, analysts clearly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.96
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 5.1% of Natera shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Natera had 2 more articles in the media than Guardant Health. MarketBeat recorded 11 mentions for Natera and 9 mentions for Guardant Health. Natera's average media sentiment score of 0.99 beat Guardant Health's score of 0.10 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	17.67	-$416.28M	-$3.39	N/A
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A

Guardant Health has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market.

Summary

Natera beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Natera compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

BrightSpring Health Services has a beta of 1.87, suggesting that its share price is 87% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

99.9% of Natera shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BrightSpring Health Services has a net margin of 2.27% compared to Natera's net margin of -9.05%. BrightSpring Health Services' return on equity of 14.63% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Natera	-9.05%	-14.74%	-10.27%

BrightSpring Health Services has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	1.02	$190.67M	$1.41	47.40
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A

In the previous week, Natera had 8 more articles in the media than BrightSpring Health Services. MarketBeat recorded 11 mentions for Natera and 3 mentions for BrightSpring Health Services. Natera's average media sentiment score of 0.99 beat BrightSpring Health Services' score of 0.88 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BrightSpring Health Services currently has a consensus price target of $61.27, suggesting a potential downside of 8.34%. Natera has a consensus price target of $257.71, suggesting a potential upside of 9.77%. Given Natera's higher possible upside, analysts plainly believe Natera is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81

Summary

BrightSpring Health Services beats Natera on 10 of the 16 factors compared between the two stocks.

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 99.9% of Natera shares are held by institutional investors. 5.1% of Natera shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, suggesting a potential upside of 17.99%. Natera has a consensus price target of $257.71, suggesting a potential upside of 9.77%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, meaning that its share price is 20% less volatile than the broader market. Comparatively, Natera has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Natera	-9.05%	-14.74%	-10.27%

In the previous week, Natera had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for Natera and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 0.99 beat Fresenius Medical Care AG & Co. KGaA's score of 0.85 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.58	$1.11B	$1.90	12.49
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Natera compare to Hims & Hers Health?

Natera (NASDAQ:NTRA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

Natera has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the broader market.

99.9% of Natera shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.1% of Natera shares are owned by insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hims & Hers Health has a net margin of -0.56% compared to Natera's net margin of -9.05%. Hims & Hers Health's return on equity of 6.10% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
Hims & Hers Health	-0.56%	6.10%	1.52%

Natera presently has a consensus target price of $257.71, suggesting a potential upside of 9.77%. Hims & Hers Health has a consensus target price of $29.37, suggesting a potential downside of 11.01%. Given Natera's stronger consensus rating and higher possible upside, equities analysts plainly believe Natera is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Hims & Hers Health has higher revenue and earnings than Natera. Hims & Hers Health is trading at a lower price-to-earnings ratio than Natera, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A
Hims & Hers Health	$2.37B	3.22	$128.37M	-$0.09	N/A

In the previous week, Hims & Hers Health had 14 more articles in the media than Natera. MarketBeat recorded 25 mentions for Hims & Hers Health and 11 mentions for Natera. Natera's average media sentiment score of 0.99 beat Hims & Hers Health's score of 0.55 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	12 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hims & Hers Health beats Natera on 9 of the 17 factors compared between the two stocks.

How does Natera compare to PACS Group?

Natera (NASDAQ:NTRA) and PACS Group (NYSE:PACS) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

PACS Group has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natera	$2.31B	14.58	-$208.16M	-$1.63	N/A
PACS Group	$5.29B	1.12	$191.54M	$1.56	23.90

Natera currently has a consensus price target of $257.71, suggesting a potential upside of 9.77%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 28.72%. Given PACS Group's higher probable upside, analysts clearly believe PACS Group is more favorable than Natera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natera	1 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.81
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

99.9% of Natera shares are owned by institutional investors. 5.1% of Natera shares are owned by insiders. Comparatively, 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

PACS Group has a net margin of 4.49% compared to Natera's net margin of -9.05%. PACS Group's return on equity of 26.47% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natera	-9.05%	-14.74%	-10.27%
PACS Group	4.49%	26.47%	4.36%

In the previous week, Natera had 1 more articles in the media than PACS Group. MarketBeat recorded 11 mentions for Natera and 10 mentions for PACS Group. Natera's average media sentiment score of 0.99 beat PACS Group's score of -0.05 indicating that Natera is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natera	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

PACS Group beats Natera on 9 of the 16 factors compared between the two stocks.

Get Natera News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NTRA vs. The Competition

Export

Metric	Natera	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$32.77B	$8.69B	$6.44B	$12.38B
Dividend Yield	N/A	1.72%	2.69%	5.83%
P/E Ratio	-144.02	23.42	24.66	23.99
Price / Sales	14.58	16.89	527.00	106.82
Price / Cash	N/A	98.97	44.82	54.51
Price / Book	18.96	5.71	10.75	6.50
Net Income	-$208.16M	$174.80M	$3.56B	$336.88M
7 Day Performance	3.67%	0.15%	1.00%	-0.14%
1 Month Performance	15.54%	1.54%	0.43%	0.77%
1 Year Performance	36.59%	8.61%	29.69%	28.49%

Natera Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NTRA Natera	3.4106 of 5 stars	$234.76 +2.6%	$257.71 +9.8%	+37.8%	$32.77B	$2.31B	N/A	6,140	Analyst Forecast
GH Guardant Health	2.119 of 5 stars	$128.83 -2.2%	$141.95 +10.2%	+169.5%	$17.47B	$982.02M	N/A	2,506	Insider Trade
BTSG BrightSpring Health Services	4.0757 of 5 stars	$67.20 +1.4%	$61.27 -8.8%	+193.5%	$13.07B	$12.91B	47.66	23,500	Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.3857 of 5 stars	$23.40 -0.8%	$28.00 +19.7%	-12.6%	$12.74B	$22.20B	12.31	1,488	News Coverage
HIMS Hims & Hers Health	3.0864 of 5 stars	$33.60 -5.3%	$29.37 -12.6%	-21.6%	$8.21B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NTRA) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

How does Natera compare to Guardant Health?

Summary

How does Natera compare to BrightSpring Health Services?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Natera compare to Hims & Hers Health?

Summary

How does Natera compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Natera (NTRA) Competitors

NTRA vs. GH, BTSG, FMS, HIMS, and PACS

How does Natera compare to Guardant Health?

Is GH or NTRA more profitable?

Do analysts rate GH or NTRA?

Do institutionals and insiders believe in GH or NTRA?

Does the media favor GH or NTRA?

Which has better earnings and valuation, GH or NTRA?

Which has more volatility and risk, GH or NTRA?

Summary

How does Natera compare to BrightSpring Health Services?

Which has more volatility and risk, BTSG or NTRA?

Do institutionals and insiders hold more shares of BTSG or NTRA?

Is BTSG or NTRA more profitable?

Which has stronger valuation and earnings, BTSG or NTRA?

Does the media favor BTSG or NTRA?

Do analysts recommend BTSG or NTRA?

Summary

How does Natera compare to Fresenius Medical Care AG & Co. KGaA?

Do insiders & institutionals hold more shares of FMS or NTRA?

Do analysts rate FMS or NTRA?

Which has more volatility and risk, FMS or NTRA?

Is FMS or NTRA more profitable?

Does the media favor FMS or NTRA?

Which has better valuation and earnings, FMS or NTRA?

Summary

How does Natera compare to Hims & Hers Health?

Which has more volatility and risk, NTRA or HIMS?

Do institutionals and insiders hold more shares of NTRA or HIMS?

Is NTRA or HIMS more profitable?

Do analysts recommend NTRA or HIMS?

Which has preferable valuation and earnings, NTRA or HIMS?

Does the media refer more to NTRA or HIMS?

Summary

How does Natera compare to PACS Group?

Which has stronger earnings & valuation, NTRA or PACS?

Do analysts recommend NTRA or PACS?

Do institutionals & insiders hold more shares of NTRA or PACS?

Is NTRA or PACS more profitable?

Does the media favor NTRA or PACS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NTRA vs. The Competition

Natera Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools